Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

2.

Screening for colorectal cancer in Italy: 2011-2012 survey.

Zorzi M, Mangone L, Anghinoni E, Baracco S, Borciani E, Caldarella A, Falcini F, Fanetti AC, Ferretti S, Giorgi Rossi P, Michiara M, Randi G, Stracci F, Vicentini M, Zucchetto A, Zappa M; IMPATTO COLONRETTO working group.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):108-14.

3.

Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.

AIRTUM Working Group.

Epidemiol Prev. 2014 Nov-Dec;38(6 Suppl 1):1-122. English, Italian. Erratum in: Epidemiol Prev. 2016 Jan-Feb;40(1):76.

4.

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.

Tinari N, Fanizza C, Romero M, Gambale E, Moscetti L, Vaccaro A, Seminara P, Longo F, Gori S, Vici P, Gamucci T, Mauri M, Laudadio L, Nuzzo A, Fabbri MA, Fattoruso SI, Mazzilli L, Grassadonia A, Cianchetti E, Natoli C.

Clin Breast Cancer. 2015 Apr;15(2):e131-7. doi: 10.1016/j.clbc.2014.10.005. Epub 2014 Oct 22.

5.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

6.

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.

Maugeri-SaccĂ  M, Pizzuti L, Sergi D, Barba M, Belli F, Fattoruso S, Giannarelli D, Amodio A, Boggia S, Vici P, Di Lauro L.

J Exp Clin Cancer Res. 2013 Sep 17;32:67. doi: 10.1186/1756-9966-32-67.

7.

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.

Di Lauro L, Vici P, Belli F, Tomao S, Fattoruso SI, Arena MG, Pizzuti L, Giannarelli D, Paoletti G, Barba M, Sergi D, Maugeri-SaccĂ  M.

Gastric Cancer. 2014 Oct;17(4):718-24. doi: 10.1007/s10120-013-0321-3. Epub 2013 Dec 8.

PMID:
24318671
8.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

9.

Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer.

Pacetti U, Veltri E, Fattoruso SI, Cardillo FD, Evangelista S, Cognetti F, Fabi A.

Anticancer Res. 2013 Apr;33(4):1721-4.

PMID:
23564822
10.

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M.

Anticancer Res. 2009 May;29(5):1841-5.

11.

[Fiberoptic bronchoscopy as diagnostic tool in primitive lung cancer].

Filippetti M, Visca P, Bordignon V, Sergi D, Marolla P, Ferretti G, Tonachella R, Corzani F, Fattoruso SI, Di Lauro L.

Clin Ter. 2009;160(1):43-6. Italian.

PMID:
19290411
12.

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

Di Lauro L, Giacinti L, Arena MG, Sergi D, Fattoruso SI, Giannarelli D, Lopez M.

J Exp Clin Cancer Res. 2009 Mar 9;28:34. doi: 10.1186/1756-9966-28-34.

13.

Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

Vici P, Viola G, Rossi S, Botti C, Vitucci C, Sergi D, Ferranti FR, Saracca E, Di Lauro L, Corsetti S, Foggi P, Fattoruso SI, Lopez M.

Clin Ter. 2008 Nov-Dec;159(6):453-6. Review.

PMID:
19169608
14.

Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

Vici P, Viola G, Botti C, Rossi S, Vitucci C, Corsetti S, Di Lauro L, Sergi D, Foggi P, Perri P, Tirelli C, Mottolese M, Fattoruso SI, Lopez M.

Clin Ter. 2008 Nov-Dec;159(6):449-52. Review.

PMID:
19169607
15.

[Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].

Fattoruso SI, Rossi S, Vici P, Di Filippo F, Botti C, Di Lauro L, Foggi P, Saracca E, Ferranti FR, Visca P, Lopez M.

Clin Ter. 2008 Nov-Dec;159(6):443-7. Review. Italian.

PMID:
19169606
16.

[Development of docetaxel in the adjuvant chemotherapy of breast cancer].

Fattoruso SI, Rossi S, Di Lauro L, Botti C, Vici P, Lopez M.

Clin Ter. 2008 Sep-Oct;159(5):369-76. Review. Italian.

PMID:
18998039
17.

[Molecular approach in the treatment of dermatofibrosarcoma protuberans].

Fattoruso SI, Visca P, Lopez M.

Clin Ter. 2008 Sep-Oct;159(5):361-7. Review. Italian.

PMID:
18998038
18.

A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.

Vici P, Di Lauro L, Sergi D, Foggi P, Viola G, Mottolese M, Giotta F, Fattoruso SI, Corsetti S, Giannarelli D, Botti C, Lopez M.

Oncology. 2008;75(3-4):175-81. doi: 10.1159/000163056. Epub 2008 Oct 8.

PMID:
18841031
19.

[A step foward in the treatment of GIST].

Fattoruso SI, Lopez M.

Clin Ter. 2008 Jul-Aug;159(4):223-4. Italian. No abstract available.

PMID:
18776977
20.

[Target selectivity of anticancer drugs].

Fattoruso SI, Di Lauro L, Conti F, Amodio A, Lopez M.

Clin Ter. 2008 May-Jun;159(3):189-206. Italian.

PMID:
18594750

Supplemental Content

Loading ...
Support Center